COMMUNIQUÉS West-GlobeNewswire

Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019
14/11/2018
NOVATO, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Helomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancer
14/11/2018
Helomics will utilize whole genome and outcome data from the U.K. 100,000 Genomes Project to advance its artificial intelligence-based platform for ovarian cancer. PITTSBURGH and LONDON, Nov. 14, 2018 (GLOBE NEWSWIRE [...]
Veritas Announces Binding Share Purchase Agreement with Leis Industries Limited for Sale of Sechelt Organic Marijuana
14/11/2018
VANCOUVER, British Columbia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that it has entered into a binding [...]
Introducing Veradigm™ Providing Next Generation Healthcare Solutions for Today’s Healthcare Challenges
14/11/2018
Data-driven insight and solutions CHICAGO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ: MDRX) announced Veradigm as the new branding for Allscripts’ Payer & Life Sciences division. Veradigm is a [...]
Replimune Reports Financial Results for the Second Fiscal Quarter, Ended September 30, and Provides Development and Corporate Update
14/11/2018
U.S. Clinical Sites for Phase 1/2 Trial of RP1 in Patients with Solid Tumors on Track to Initiate by End of Year Additional Product Candidates RP2 and RP3 Continue to Advance Toward the Clinic WOBURN, Mass., Nov. 14, [...]
Inspire Medical Systems, Inc. to Present at the 30th Annual Piper Jaffray Healthcare Conference
14/11/2018
MINNEAPOLIS, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019
14/11/2018
Reports over $52 million of cash-on-hand with Company now fully funded beyond completion of the TRILOGY Phase 3 studies Both TRILOGY studies surpass 90% enrollment and remain on track to report topline results in 2019 [...]
Ovid Therapeutics to Present at 30th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27
14/11/2018
NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]
Gritstone Oncology Reports Third Quarter 2018 Financial Results and Recent Business Highlights
14/11/2018
Successful Initial Public Offering Raises $95.6 Million in Net Proceeds EMERYVILLE, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing [...]
Reflect Scientific Reports Strong Sales - Cryometrix Freezers Lead
14/11/2018
OREM, Utah, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (OTC:RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries announces a 27% year [...]
NanoVibronix Provides Business Update for the Third Quarter of 2018
14/11/2018
Lays out key upcoming milestones for the next 12 months ELMSFORD, N.Y., Nov. 14, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low [...]
Entasis Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update
14/11/2018
Completed $75.0 million initial public offering in September Reported positive Phase 2 topline results of lead program ETX2514SUL On-track to initiate two Phase 3 clinical trials in 2019 WALTHAM, Mass., Nov. 14, 2018 ( [...]
Eidos Therapeutics to Present at Two Upcoming Investor Conferences
14/11/2018
SAN FRANCISCO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced that management will present a company overview at two upcoming investor conferences. Piper Jaffray [...]
Rexahn Pharmaceuticals Announces Leadership Transition
14/11/2018
Douglas Swirsky Assumes Role of Chief Executive Officer ROCKVILLE, Md., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing [...]
PotNetwork Holdings’ Diamond CBD Engages With Fellow Industry Leaders at MJBizCon
14/11/2018
Diamond CBD Features Latest Products at Booth 4517 , During Marijuana Business Daily’s Flagship Event at the Las Vegas Convention Center FORT LAUDERDALE, Fla., Nov. 14, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- [...]
Spectral Announces Third Quarter Results
14/11/2018
TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT) , a Phase III company developing the first treatment for patients with septic shock guided by a companion diagnostic, today announced its [...]
Cue Biopharma to Host Business Update Call and Webcast
14/11/2018
CAMBRIDGE, Mass., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human [...]
RedHill Biopharma Announces Presentation on YELIVA® (opaganib) for Multiple Myeloma at EORTC-NCI-AACR Symposium
14/11/2018
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Canntab Corporate Update
14/11/2018
TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited ( CSE: PILL , FSE: TBF1) (“Canntab” or the “Company”) is a company with a clear vision of becoming the leader in solid oral dosage formulation of [...]

Pages